Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Antibiotic Analgesic-Sedative and Antiseizure Medications Frequently Used in Critically Ill Neonates: A Narrative Review

Version 1 : Received: 1 May 2024 / Approved: 3 May 2024 / Online: 3 May 2024 (11:22:30 CEST)

How to cite: Kontou, A.; Agakidou, E.; Chatziioannidis, I.; Chotas, W.; Thomaidou, E.; Sarafidis, K. Antibiotic Analgesic-Sedative and Antiseizure Medications Frequently Used in Critically Ill Neonates: A Narrative Review. Preprints 2024, 2024050151. https://doi.org/10.20944/preprints202405.0151.v1 Kontou, A.; Agakidou, E.; Chatziioannidis, I.; Chotas, W.; Thomaidou, E.; Sarafidis, K. Antibiotic Analgesic-Sedative and Antiseizure Medications Frequently Used in Critically Ill Neonates: A Narrative Review. Preprints 2024, 2024050151. https://doi.org/10.20944/preprints202405.0151.v1

Abstract

Several studies have shown that antibiotics, analgesic – sedative, and antiseizure medications are among the most commonly used medications in preterm and sick neonates. These infants are at high risk of developing nosocomial infections, central nervous system complications, and are exposed to numerous painful/stressful procedures. These severe, potentially life-threatening complications may have serious short- and long-term consequences and should be prevented and/or promptly treated. Previous studies and reviews have revealed significant variability in medications used in neonatal intensive care units (NICUs) worldwide, especially concerning the indications and dosages of first-line medications. This variability indicates the lack of adequate studies regarding the effectiveness and safety of these medications in neonates, especially the preterm ones. Important obstacles contributing to inadequate studies in preterm infants include difficulties in obtaining parental consent, physicians’ unwillingness to recruit preterm infants, the lack of license for use in neonates, and other scientific and ethical concerns. This review is an update on the use of antimicrobials – antifungals, analgesics – sedatives, and antiseizure medications used in neonates, focusing on existing evidence or knowledge gaps regarding their pharmacokinetics, indications, safety, dosage regimen (dose, dosing interval, route of administration), and evidence-based guidelines for the optimal use in neonates.

Keywords

neonatal infections; sepsis; antibiotics; antifungal; analgesics; sedatives; seizures; medications; pharmacokinetics; neonatal pain; preterm infants

Subject

Medicine and Pharmacology, Pediatrics, Perinatology and Child Health

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.